ACSI:: Enhancing Circulation

Circulatory Enhancer Technology Overview

ResQPOD Impedance Threshold Device

Product Features

Technology

FAQs

Published Articles

Clinical Information

American Heart
Association Guidelines

Circulatory Enhancement Applications

Sudden Cardiac Arrest

Hypotension

Blood Loss

Instructions for Use

Product Literature
and Video

ResQGARD Impedance Threshold Device

Home

Advanced Circulatory
Systems, Inc.
7615 Golden Triangle Drive,
Suite A
Eden Prairie, MN 55344
877-RESQPOD
1-877-737-7763
www.advancedcirculatory.com

Clinical Information

The ResQPOD Circulatory Enhancer � Cardiac Arrest has been proven in clinical trials conducted in France, Germany, the United Kingdom and the United States to: Be Safe and Effective Increase Blood Pressure Increase Cardiac Output Increase the Opportunity for Survival from Cardiac Arrest Improve the Opportunity for Complete Neurological Recovery Click here to see a Key Study Summary for the ResQPOD
Increases Blood Pressure

Increases Cardiac Output

Increases Opportunity for Survival



Improves Opportunity for Complete Neurological Recovery

The generally cleared indication for the ResQPOD is a temporary increase in blood circulation during emergency care, hospital, clinic and home use. Click here to review the Instructions for Use. Studies are ongoing in the United States to evaluate the
long-term benefit of the ResQPOD for indications related to patients suffering from cardiac arrest, hypotension during dialysis
and severe blood loss.

For more information on completed clinical studies click here. The references on this website are not intended to imply specific outcome-based claims not yet cleared by the US Food and Drug Administration.